• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌:对早期胃癌新见解的最新综述

Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer.

作者信息

Mazurek Marek, Szewc Monika, Sitarz Monika Z, Dudzińska Ewa, Sitarz Robert

机构信息

Department of Surgical Oncology, Masovian Cancer Hospital, 05-135 Wieliszew, Poland.

Department of Normal, Clinical and Imaging Anatomy, Medical University of Lublin, 20-950 Lublin, Poland.

出版信息

Cancers (Basel). 2024 Sep 15;16(18):3163. doi: 10.3390/cancers16183163.

DOI:10.3390/cancers16183163
PMID:39335135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11430327/
Abstract

Gastric cancer (GC) is the fifth most frequently diagnosed cancer and the fifth most common cause of cancer death in the world. Regarding the age at which the diagnosis was made, GC is divided into early-onset gastric cancer (EOGC-up to 45 years of age) and conventional GC (older than 45). EOGC constitutes approximately 10% of all GCs. Numerous reports indicate that EOGC is more aggressive than conventional GC and is often discovered at an advanced tumor stage, which has an impact on the five-year survival rate. The median survival rate for advanced-stage GC is very poor, amounting to less than 12 months. Risk factors for GC include family history, alcohol consumption, smoking, , and Epstein-Barr virus infection. It has been shown that a proper diet and lifestyle can play a preventive role in GC. However, research indicates that risk factors for conventional GC are less correlated with EOGC. In addition, the unclear etiology of EOGC and the late diagnosis of this disease limit the possibilities of effective treatment. Genetic factors are considered a likely cause of EOGC, as young patients are less exposed to environmental carcinogens. Research characterizing GC in young patients is scarce. This comprehensive study presents all aspects: epidemiology, risk factors, new treatment strategies, and future directions.

摘要

胃癌(GC)是全球第五大最常被诊断出的癌症,也是癌症死亡的第五大常见原因。就诊断时的年龄而言,GC分为早发性胃癌(EOGC,45岁及以下)和传统GC(45岁以上)。EOGC约占所有GC的10%。大量报告表明,EOGC比传统GC更具侵袭性,且常在肿瘤晚期被发现,这对五年生存率有影响。晚期GC的中位生存率非常低,不到12个月。GC的风险因素包括家族史、饮酒、吸烟和爱泼斯坦 - 巴尔病毒感染。研究表明,合理的饮食和生活方式对GC可起到预防作用。然而,研究表明,传统GC的风险因素与EOGC的相关性较小。此外,EOGC病因不明以及该病诊断较晚限制了有效治疗的可能性。遗传因素被认为是EOGC的一个可能原因,因为年轻患者接触环境致癌物较少。关于年轻患者GC特征的研究很少。这项综合性研究呈现了各个方面:流行病学、风险因素、新的治疗策略以及未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf8/11430327/bfae327065c9/cancers-16-03163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf8/11430327/5cb0254c8e41/cancers-16-03163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf8/11430327/bfae327065c9/cancers-16-03163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf8/11430327/5cb0254c8e41/cancers-16-03163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcf8/11430327/bfae327065c9/cancers-16-03163-g002.jpg

相似文献

1
Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer.胃癌:对早期胃癌新见解的最新综述
Cancers (Basel). 2024 Sep 15;16(18):3163. doi: 10.3390/cancers16183163.
2
The Endoscopic and Clinicopathological Characteristics of Early-onset Gastric Cancer in Vietnamese Patients.越南患者早发性胃癌的内镜及临床病理特征
Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1883-1886. doi: 10.22034/APJCP.2018.19.7.1883.
3
Programmed death-1 and PD-1 ligand-1 expression in early onset gastric carcinoma and correlation with clinicopathological characteristics.程序性死亡蛋白-1及程序性死亡蛋白-1配体-1在早期胃癌中的表达及其与临床病理特征的相关性
Int J Clin Exp Pathol. 2018 Apr 1;11(4):1989-1998. eCollection 2018.
4
Comparative investigation of early-onset gastric cancer.早发性胃癌的对比研究
Oncol Lett. 2021 May;21(5):374. doi: 10.3892/ol.2021.12635. Epub 2021 Mar 13.
5
Molecular alterations in gastric cancer with special reference to the early-onset subtype.胃癌的分子改变,特别涉及早发型亚型。
World J Gastroenterol. 2016 Feb 28;22(8):2460-74. doi: 10.3748/wjg.v22.i8.2460.
6
Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer.早发性和传统型胃癌患者中CHEK2和p53的状态
Oncol Lett. 2021 May;21(5):348. doi: 10.3892/ol.2021.12609. Epub 2021 Mar 3.
7
Early-onset gastric cancer: Learning lessons from the young.早期胃癌:从年轻人身上吸取教训。
World J Gastrointest Oncol. 2010 Feb 15;2(2):59-64. doi: 10.4251/wjgo.v2.i2.59.
8
The clinicopathological characteristics of early-onset gastric cancer and its evolutionary trends: a retrospective study.早发性胃癌的临床病理特征及其演变趋势:一项回顾性研究。
Am J Cancer Res. 2022 Jun 15;12(6):2757-2769. eCollection 2022.
9
Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer.早发性胃癌患者治疗模式的差异。
Cancers (Basel). 2022 Jul 26;14(15):3633. doi: 10.3390/cancers14153633.
10
A Distinct Clinicopathological Feature and Prognosis of Young Gastric Cancer Patients Aged ≤ 45 Years Old.年龄≤45岁的年轻胃癌患者的独特临床病理特征及预后
Front Oncol. 2021 Aug 26;11:674224. doi: 10.3389/fonc.2021.674224. eCollection 2021.

引用本文的文献

1
Global burden of gastric cancer attributed to high-salt diets: spatiotemporal trends and socio-demographic inequalities from 1990 to 2021.高盐饮食导致的胃癌全球负担:1990年至2021年的时空趋势及社会人口不平等状况
J Gastrointest Oncol. 2025 Aug 30;16(4):1403-1419. doi: 10.21037/jgo-2025-200. Epub 2025 Aug 27.
2
Early onset gastric cancer: clinical and molecular insights into a rising epidemic among younger adults.早期胃癌:对年轻成年人中日益流行的一种疾病的临床与分子见解
Proc (Bayl Univ Med Cent). 2025 Apr 22;38(4):388-396. doi: 10.1080/08998280.2025.2488592. eCollection 2025.
3
Epidemiology of Helicobacter pylori, gastric precancerous lesions and gastric cancer: a multicenter, population-based cross-sectional study in Nanjing.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis.Toll样受体家族基因的常见变异与胃癌风险:一项系统评价和荟萃分析
Front Genet. 2023 Nov 28;14:1280051. doi: 10.3389/fgene.2023.1280051. eCollection 2023.
3
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial.
幽门螺杆菌、胃癌前病变及胃癌的流行病学:一项基于南京多中心人群的横断面研究
BMC Infect Dis. 2025 May 27;25(1):766. doi: 10.1186/s12879-025-11147-3.
4
Glycoproteomics of Gastrointestinal Cancers and Its Use in Clinical Diagnostics.胃肠道癌症的糖蛋白质组学及其在临床诊断中的应用
J Proteome Res. 2025 Jun 6;24(6):2584-2599. doi: 10.1021/acs.jproteome.5c00095. Epub 2025 May 14.
5
Chemotherapy Options for Locally Advanced Gastric Cancer: A Review.局部进展期胃癌的化疗方案综述
Cancers (Basel). 2025 Feb 26;17(5):809. doi: 10.3390/cancers17050809.
6
Spectrum of Upper Gastrointestinal Diseases in Patients Presenting with Dyspepsia-A First Report from Myanmar.消化不良患者的上消化道疾病谱——来自缅甸的首份报告
JGH Open. 2025 Feb 18;9(2):e70121. doi: 10.1002/jgh3.70121. eCollection 2025 Feb.
腹腔内热灌注化疗对胃癌合并腹膜转移患者细胞减灭术的影响:GASTRIPEC-I 期临床试验。
J Clin Oncol. 2024 Jan 10;42(2):146-156. doi: 10.1200/JCO.22.02867. Epub 2023 Oct 31.
4
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.帕博利珠单抗联合化疗对比安慰剂联合化疗用于 HER2 阴性晚期胃癌(KEYNOTE-859):一项多中心、随机、双盲、III 期临床试验。
Lancet Oncol. 2023 Nov;24(11):1181-1195. doi: 10.1016/S1470-2045(23)00515-6. Epub 2023 Oct 21.
5
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.帕博利珠单抗联合曲妥珠单抗和化疗治疗 HER2 阳性胃或胃食管交界腺癌:来自 3 期 KEYNOTE-811 随机安慰剂对照试验的中期分析。
Lancet. 2023 Dec 9;402(10418):2197-2208. doi: 10.1016/S0140-6736(23)02033-0. Epub 2023 Oct 20.
6
Development of alternative herbals remedy for gastric cancer based on transcriptomic analysis of immune infiltration and ferroptosis.基于免疫浸润和铁死亡转录组分析开发胃癌替代草药疗法
Front Genet. 2023 Mar 3;14:1086368. doi: 10.3389/fgene.2023.1086368. eCollection 2023.
7
and Gastric Cancer: Pathogenetic Mechanisms.《幽门螺杆菌感染与胃癌:发病机制》
Int J Mol Sci. 2023 Feb 2;24(3):2895. doi: 10.3390/ijms24032895.
8
Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition).日本胃癌治疗指南 2021(第 6 版)。
Gastric Cancer. 2023 Jan;26(1):1-25. doi: 10.1007/s10120-022-01331-8. Epub 2022 Nov 7.
9
Is early-onset cancer an emerging global epidemic? Current evidence and future implications.早发性癌症是一种新兴的全球流行病吗?当前证据和未来影响。
Nat Rev Clin Oncol. 2022 Oct;19(10):656-673. doi: 10.1038/s41571-022-00672-8. Epub 2022 Sep 6.
10
Gurgem-7 toxicity assessment: Regulation of cell survival or death by traditional Mongolian prescription.古日古木-7 毒性评估:传统蒙药对细胞存活或死亡的调控。
Ecotoxicol Environ Saf. 2022 Jul 1;239:113660. doi: 10.1016/j.ecoenv.2022.113660. Epub 2022 May 20.